Accessibility Menu
Incyte Stock Quote

Incyte (NASDAQ: INCY)

$88.06
(0.9%)
+0.76
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$88.06
Daily Change
(0.9%) +$0.76
Day's Range
$87.25 - $88.21
Previous Close
$88.06
Open
$87.4
Beta
0.55
Volume
1,582,675
Average Volume
1,797,510
Market Cap
17.2B
Market Cap / Employee
$88.06M
52wk Range
$53.56 - $92.86
Revenue
-
Gross Margin
0.91%
Dividend Yield
N/A
EPS
$4.4
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Incyte Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
INCY+34.26%-1.82%-0.37%+4,556%
S&P+14.5%+93.32%+14.09%+1,364%

Incyte Company Info

Incyte isn't the only drugmaker with a JAK inhibitor, but Jakafi's differentiation as a JAK1 and JAK2 inhibitor has helped the company stay on top of the treatment paradigm for myelofibrosis.

News & Analysis

The Fool has written over 200 articles on Incyte.

Financial Health

General

Q2 2025YOY Change
Revenue$1.22B16.5%
Gross Profit$1.12B17.8%
Gross Margin92.13%1.0%
Market Cap$13.18B-3.3%
Market Cap / Employee$5.04M0.0%
Employees2.6K3.7%
Net Income$405.00M191.1%
EBITDA$333.74M173.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$1.95B98.0%
Accounts Receivable$842.89M14.1%
Inventory83.4-17.2%

Liabilities

Q2 2025YOY Change
Long Term Debt$31.76M10.5%
Short Term Debt$10.65M21.0%

Ratios

Q2 2025YOY Change
Return On Assets16.61%14.8%
Return On Invested Capital6.76%-3.2%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$25.67M104.1%
Operating Free Cash Flow$44.74M107.8%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings468.13254.68187.3515.48-90.94%
Price to Book4.024.203.403.6042.60%
Price to Sales3.183.222.722.95-13.91%
Price to Tangible Book Value4.404.603.693.8845.84%
Price to Free Cash Flow TTM421.6354.7539.6414.13-13.70%
Enterprise Value to EBITDA58.3636.0340.3033.42-229.55%
Free Cash Flow Yield0.2%1.8%2.5%7.1%15.88%
Return on Equity0.8%0.8%0.5%24.3%866.23%
Total Debt$36.51M$60.34M$43.12M$42.41M12.94%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.